SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-009021
Filing Date
2022-03-11
Accepted
2022-03-11 08:54:18
Documents
14
Period of Report
2022-03-11
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10035049_8k.htm   iXBRL 8-K 48412
2 EXHIBIT 3.1 brhc10035049_ex3-1.htm EX-3.1 18131
3 EXHIBIT 3.2 brhc10035049_ex3-2.htm EX-3.2 67784
  Complete submission text file 0001140361-22-009021.txt   300839

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arna-20220311.xsd EX-101.SCH 3929
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20220311_lab.xml EX-101.LAB 23289
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20220311_pre.xml EX-101.PRE 16554
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10035049_8k_htm.xml XML 4393
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 22731283
SIC: 2834 Pharmaceutical Preparations